These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36432436)

  • 41. Dietary Approaches for Management of Non-Alcoholic Fatty Liver Disease: A Clinician's Guide.
    Aboubakr A; Stroud A; Kumar S; Newberry C
    Curr Gastroenterol Rep; 2021 Oct; 23(12):21. PubMed ID: 34654976
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of Mediterranean diet on hepatic steatosis, oxidative stress, and inflammation in adolescents with non-alcoholic fatty liver disease: A randomized controlled trial.
    Yurtdaş G; Akbulut G; Baran M; Yılmaz C
    Pediatr Obes; 2022 Apr; 17(4):e12872. PubMed ID: 34881510
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [ANTHROPOMETRIC CHARACTERISTICS AND PARAMETERS OF LIPID-CARBOHYDRATE METABOLISM IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE AND HYPERTENSION DEPENDING ON THE DEGREE OF HEPATIC STEATOSIS].
    Babak О; Bashkirova А
    Georgian Med News; 2018 Nov; (284):59-65. PubMed ID: 30618391
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Serum Wnt5a and Its Associations with Liver Steatosis and Fibrosis in Overweight and Obese People].
    Liang LB; Wang X; He H; Gao Y; Jia D; An ZM; Li SQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Jan; 48(1):7-11. PubMed ID: 28612550
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
    Florakis D; Diamanti-Kandarakis E; Katsikis I; Nassis GP; Karkanaki A; Georgopoulos N; Panidis D
    Int J Obes (Lond); 2008 Apr; 32(4):692-9. PubMed ID: 18071341
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regular exercise coupled to diet regimen accelerates reduction of hepatic steatosis and associated pathological conditions in nonalcoholic fatty liver disease.
    Oh S; Tanaka K; Tsujimoto T; So R; Shida T; Shoda J
    Metab Syndr Relat Disord; 2014 Jun; 12(5):290-8. PubMed ID: 24689911
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative study of overweight and obese patients with nonalcoholic fatty liver disease.
    Aller R; Burgueño Gomez B; Sigüenza R; Fernández-Rodríguez C; Fernández N; Antolín B; Durà M; Pina M; Lorenzo S; García C; de Luis Román D
    Rev Esp Enferm Dig; 2019 Apr; 111(4):256-263. PubMed ID: 30746959
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Effects of Eight Weeks' Very Low-Calorie Ketogenic Diet (VLCKD) on Liver Health in Subjects Affected by Overweight and Obesity.
    Rinaldi R; De Nucci S; Castellana F; Di Chito M; Giannuzzi V; Shahini E; Zupo R; Lampignano L; Piazzolla G; Triggiani V; Cozzolongo R; Giannelli G; De Pergola G
    Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839183
    [TBL] [Abstract][Full Text] [Related]  

  • 49. OBESITY AND SEVERE STEATOSIS: THE IMPORTANCE OF BIOCHEMICAL EXAMS AND SCORES.
    Silva MBBE; Tustumi F; Dantas ACB; Miranda BCJ; Pajecki D; DE-Cleva R; Santo MA; Nahas SC
    Arq Bras Cir Dig; 2022; 34(4):e1626. PubMed ID: 35107488
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The relationship between Lipocalin-2 level and hepatic steatosis in obese patients with NAFLD after bariatric surgery.
    Chen J; Lei S; Huang Y; Zha X; Gu L; Zhou D; Li J; Liu F; Li N; Du L; Huang X; Lin Z; Bu L; Qu S
    Lipids Health Dis; 2022 Jan; 21(1):10. PubMed ID: 35034646
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Calorie-Restricted Mediterranean and Low-Fat Diets Affect Fatty Acid Status in Individuals with Nonalcoholic Fatty Liver Disease.
    Ristic-Medic D; Kovacic M; Takic M; Arsic A; Petrovic S; Paunovic M; Jovicic M; Vucic V
    Nutrients; 2020 Dec; 13(1):. PubMed ID: 33374554
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease.
    Gelli C; Tarocchi M; Abenavoli L; Di Renzo L; Galli A; De Lorenzo A
    World J Gastroenterol; 2017 May; 23(17):3150-3162. PubMed ID: 28533672
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatic Steatosis Is Associated with Elevated Serum Iron in Patients with Obesity and Improves after Laparoscopic Sleeve Gastrectomy.
    Ma B; Sun H; Zhu B; Wang S; Du L; Wang X; Qu S
    Obes Facts; 2021; 14(1):64-71. PubMed ID: 33352578
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exercise and diet modification in non-obese non-alcoholic fatty liver disease: analysis of biopsies of living liver donors.
    Jin YJ; Kim KM; Hwang S; Lee SG; Ha TY; Song GW; Jung DH; Kim KH; Yu E; Shim JH; Lim YS; Lee HC; Chung YH; Lee Y; Suh DJ
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1341-7. PubMed ID: 22554085
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preoperative circulating peroxiredoxin 1 levels as a predictor of non-alcoholic fatty liver disease remission after laparoscopic bariatric surgery.
    Cheng X; Fu Z; Xie W; Zhu L; Meng J
    Front Endocrinol (Lausanne); 2022; 13():1072513. PubMed ID: 36619535
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Liver fat accumulation more than fibrosis causes early liver dynamic dysfunction in patients with non-alcoholic fatty liver disease.
    Di Ciaula A; Shanmugam H; Ribeiro R; Pina A; Andrade R; Bonfrate L; Raposo JF; Macedo MP; Portincasa P
    Eur J Intern Med; 2023 Jan; 107():52-59. PubMed ID: 36344354
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Silymarin in Combination with Vitamin C, Vitamin E, Coenzyme Q10 and Selenomethionine to Improve Liver Enzymes and Blood Lipid Profile in NAFLD Patients.
    Curcio A; Romano A; Cuozzo S; Nicola AD; Grassi O; Schiaroli D; Nocera GF; Pironti M
    Medicina (Kaunas); 2020 Oct; 56(10):. PubMed ID: 33080906
    [No Abstract]   [Full Text] [Related]  

  • 58. Anthropometric and blood parameters for the prediction of NAFLD among overweight and obese adults.
    Kühn T; Nonnenmacher T; Sookthai D; Schübel R; Quintana Pacheco DA; von Stackelberg O; Graf ME; Johnson T; Schlett CL; Kirsten R; Ulrich CM; Kaaks R; Kauczor HU; Nattenmüller J
    BMC Gastroenterol; 2018 Jul; 18(1):113. PubMed ID: 30005625
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pediatric non-alcoholic fatty liver disease: an increasing public health issue.
    Berardis S; Sokal E
    Eur J Pediatr; 2014 Feb; 173(2):131-9. PubMed ID: 24068459
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of garlic powder supplementation on hepatic steatosis, liver enzymes and lipid profile in patients with non-alcoholic fatty liver disease: a double-blind randomised controlled clinical trial.
    Sangouni AA; Mohammad Hosseini Azar MR; Alizadeh M
    Br J Nutr; 2020 Aug; 124(4):450-456. PubMed ID: 32312333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.